comparemela.com
Home
Live Updates
Algernon Pharmaceuticals Inc. Announces Notice of Allowance for Ifenprodil Patent in Japan for Idiopathic Pulmonary Fibrosis : comparemela.com
Algernon Pharmaceuticals Inc. Announces Notice of Allowance for Ifenprodil Patent in Japan for Idiopathic Pulmonary Fibrosis
Algernon Pharmaceuticals Inc. announced that it has received a notice of allowance from the Japanese Patent Office for patent application No. 2021-547495 entitled: Compositions and Methods for...
Related Keywords
Canada ,
Japan ,
China ,
Japanese ,
,
Algernon Pharmaceuticals Inc ,
Japanese Patent Office ,
Algernon Pharmaceuticals ,
Treating Idiopathic Pulmonary Fibrosis ,
Markets ,
comparemela.com © 2020. All Rights Reserved.